rfcnu has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bothorel, P; Mathé, G | 1 |
| Bourut, C; Chenu, E; Hayat, M; Imbach, JL; MacDonald, JS; Mathé, G; Montero, JL | 1 |
| Andrade Mena, CE; Cosmatopoulos, K; Mathé, G; Orbach-Arbouys, S | 1 |
3 other study(ies) available for rfcnu and Experimental Neoplasms
| Article | Year |
|---|---|
In vivo enhancement of the experimental oncostatic effect of RFCNU by its encapsulation in liposomes.
Topics: Animals; Antineoplastic Agents; Liposomes; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitrosourea Compounds | 1981 |
Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.
Topics: Animals; Antineoplastic Agents; Half-Life; Humans; Lethal Dose 50; Leukemia L1210; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitrosourea Compounds; Streptozocin | 1979 |
Effects of three new nitrosourea analogs (CNCC, RFCNU and chlorozotocin) on in vivo destruction of L 1210 leukemia cells and on the immune response.
Topics: Animals; Antibody Formation; Bone Marrow; Drug Evaluation, Preclinical; Hemolytic Plaque Technique; Hypersensitivity, Delayed; Injections, Intraperitoneal; Leukemia L1210; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Nitrosourea Compounds; Spleen; Streptozocin | 1986 |